Published in Breast Cancer Res Treat on May 16, 2014
Genomic landscapes of breast fibroepithelial tumors. Nat Genet (2015) 0.88
Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity. Mod Pathol (2016) 0.82
Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast. Oncotarget (2016) 0.80
MED12 mutations in breast phyllodes tumors: evidence of temporal tumoral heterogeneity and identification of associated critical signaling pathways. Oncotarget (2016) 0.75
Patterns of somatic mutation in human cancer genomes. Nature (2007) 38.41
External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study. Lancet Oncol (2013) 3.19
Conditional survival of patients with metastatic renal-cell carcinoma treated with VEGF-targeted therapy: a population-based study. Lancet Oncol (2012) 2.84
An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell (2011) 2.78
Digital pathology: exploring its applications in diagnostic surgical pathology practice. Pathology (2010) 2.05
Bevacizumab and rapamycin induce growth suppression in mouse models of hepatocellular carcinoma. J Hepatol (2008) 1.87
Identification of circulating microRNA signatures for breast cancer detection. Clin Cancer Res (2013) 1.67
A molecular classification of papillary renal cell carcinoma. Cancer Res (2005) 1.60
Genomic structure of human OKL38 gene and its differential expression in kidney carcinogenesis. J Biol Chem (2003) 1.58
Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. BMC Gastroenterol (2003) 1.55
Comparison of the UCLA Integrated Staging System and the Leibovich score in survival prediction for patients with nonmetastatic clear cell renal cell carcinoma. Urology (2010) 1.52
Progression-free survival as a predictor of overall survival in metastatic renal cell carcinoma treated with contemporary targeted therapy. Cancer (2010) 1.52
Conservation of breast cancer molecular subtypes and transcriptional patterns of tumor progression across distinct ethnic populations. Clin Cancer Res (2004) 1.44
Diagnostic issues in second opinion consultations in prostate pathology. Pathology (2010) 1.42
A rare case of localised AA-type amyloidosis of the ureter with spheroids of amyloid. Singapore Med J (2012) 1.39
Predicting clinical behaviour of breast phyllodes tumours: a nomogram based on histological criteria and surgical margins. J Clin Pathol (2011) 1.38
Triple-negative breast cancer: clinicopathological characteristics and relationship with basal-like breast cancer. Mod Pathol (2009) 1.32
Hormone receptor and c-ERBB2 status in distant metastatic and locally recurrent breast cancer. Pathologic correlations and clinical significance. Am J Clin Pathol (2010) 1.29
Do primary mammary osteosarcoma and chondrosarcoma exist? A review of a large multi-institutional series of malignant matrix-producing breast tumours. Breast (2012) 1.27
Parafibromin inhibits cancer cell growth and causes G1 phase arrest. Biochem Biophys Res Commun (2006) 1.25
Triple negative breast cancer: outcome correlation with immunohistochemical detection of basal markers. Am J Surg Pathol (2010) 1.25
Development of a next-generation sequencing method for BRCA mutation screening: a comparison between a high-throughput and a benchtop platform. J Mol Diagn (2012) 1.21
Somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated [corrected] oxygen-sensing response. PLoS Genet (2008) 1.20
Solid pseudopapillary tumour of the pancreas. ANZ J Surg (2003) 1.19
Loss of viability during freeze-thaw of intact and adherent human embryonic stem cells with conventional slow-cooling protocols is predominantly due to apoptosis rather than cellular necrosis. J Biomed Sci (2005) 1.17
Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma. J Med Genet (2011) 1.14
Succinate dehydrogenase (SDH)-deficient renal carcinoma: a morphologically distinct entity: a clinicopathologic series of 36 tumors from 27 patients. Am J Surg Pathol (2014) 1.11
Two distinct types of blood vessels in clear cell renal cell carcinoma have contrasting prognostic implications. Clin Cancer Res (2007) 1.10
The pathology of dengue hemorrhagic fever. Semin Diagn Pathol (2007) 1.10
Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma. BMC Cancer (2010) 1.08
Recurrent phyllodes tumours of the breast: pathological features and clinical implications. ANZ J Surg (2006) 1.06
Cancer stem cell markers are associated with adverse biomarker profiles and molecular subtypes of breast cancer. Breast Cancer Res Treat (2012) 1.06
Antiinflammatory effects of genistein, a tyrosine kinase inhibitor, on a guinea pig model of asthma. Am J Respir Crit Care Med (2002) 1.05
Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors. Breast (2010) 1.04
Spindle cell lesions of the breast--the pathologic differential diagnosis. Breast Cancer Res Treat (2007) 1.03
c-erbB-2 (HER-2/neu) immunohistochemistry in invasive breast cancer: is there concordance between standard sections and tissue microarrays? Pathology (2006) 1.01
A molecular signature of the Nottingham prognostic index in breast cancer. Cancer Res (2004) 1.01
The Karakiewicz nomogram is the most useful clinical predictor for survival outcomes in patients with localized renal cell carcinoma. Cancer (2011) 1.00
p53-Independent regulation of p21Waf1/Cip1 expression and senescence by PRMT6. Nucleic Acids Res (2012) 0.99
Global evolutionary trend of the prevalence of primary glomerulonephritis over the past three decades. Nephron Clin Pract (2010) 0.99
VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma. Am J Transl Res (2010) 0.98
Prognostic factors in patients with diffuse large B cell lymphoma: Before and after the introduction of rituximab. Leuk Lymphoma (2008) 0.98
DEAD-box helicase DP103 defines metastatic potential of human breast cancers. J Clin Invest (2014) 0.97
Pericyte coverage of differentiated vessels inside tumor vasculature is an independent unfavorable prognostic factor for patients with clear cell renal cell carcinoma. Cancer (2012) 0.97
Sclerosing polycystic adenosis of the parotid gland: report of a bifocal, paucicystic variant with ductal carcinoma in situ and pronounced stromal distortion mimicking invasive carcinoma. Head Neck Pathol (2011) 0.97
Mixed epithelial and stromal tumour (MEST) of the kidney: a clinicopathological report of three cases. Pathology (2009) 0.96
Acute promyelocytic leukemia with PML-RARA fusion on i(17q) and therapy-related acute myeloid leukemia. Cancer Genet Cytogenet (2005) 0.96
Identification of copy number alterations and its association with pathological features in clear cell and papillary RCC. Cancer Lett (2008) 0.96
Antisense RNA down-regulation of bcl-2 expression in DU145 prostate cancer cells does not diminish the cytostatic effects of G3139 (Oblimersen). Clin Cancer Res (2004) 0.95
TP53 genomic status regulates sensitivity of gastric cancer cells to the histone methylation inhibitor 3-deazaneplanocin A (DZNep). Clin Cancer Res (2012) 0.95
The association of clinical outcome to first-line VEGF-targeted therapy with clinical outcome to second-line VEGF-targeted therapy in metastatic renal cell carcinoma patients. Target Oncol (2013) 0.95
Lactobacillus species is more cytotoxic to human bladder cancer cells than Mycobacterium Bovis (bacillus Calmette-Guerin). J Urol (2002) 0.94
Is triple immunostaining with 34betaE12, p63, and racemase in prostate cancer advantageous? A tissue microarray study. Am J Clin Pathol (2007) 0.94
Clinicopathological significance of calreticulin in breast invasive ductal carcinoma. Mod Pathol (2010) 0.94
Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer. Histopathology (2012) 0.94
Atypia in inverted urothelial papillomas: pathology and prognostic significance. Hum Pathol (2004) 0.93
Ablation of dihydroceramide desaturase 1, a therapeutic target for the treatment of metabolic diseases, simultaneously stimulates anabolic and catabolic signaling. Mol Cell Biol (2013) 0.93
Sarcomatoid renal cell carcinoma metastatic to the breast: report of a case with diagnosis on fine needle aspiration cytology. Acta Cytol (2007) 0.93
Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer Res (2004) 0.93
Predictors of phyllodes tumours on core biopsy specimens of fibroepithelial neoplasms. Histopathology (2010) 0.93
Role of IGF system of mitogens in the induction of fibroblast proliferation by keloid-derived keratinocytes in vitro. Am J Physiol Cell Physiol (2002) 0.93
Relative Bcl-2 independence of drug-induced cytotoxicity and resistance in 518A2 melanoma cells. Clin Cancer Res (2004) 0.92
Androgen receptor expression shows distinctive significance in ER positive and negative breast cancers. Ann Surg Oncol (2014) 0.91
TRARESA: a tissue microarray-based hospital system for biomarker validation and discovery. Pathology (2008) 0.91
Lactobacillus rhamnosus GG induces tumor regression in mice bearing orthotopic bladder tumors. Cancer Sci (2009) 0.91
Targets of genome copy number reduction in primary breast cancers identified by integrative genomics. Genes Chromosomes Cancer (2007) 0.91
Flat epithelial atypia: concepts and controversies of an intraductal lesion of the breast. Pathology (2005) 0.91
Juxtaglomerular cell tumor: a morphological, immunohistochemical and genetic study of six cases. Hum Pathol (2012) 0.90
Validation of the Gail model for predicting individual breast cancer risk in a prospective nationwide study of 28,104 Singapore women. Breast Cancer Res (2012) 0.90
Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT. J Photochem Photobiol B (2005) 0.89
Role of sunitinib and SU12662 on dermatological toxicities in metastatic renal cell carcinoma patients: in vitro, in vivo, and outcomes investigation. Cancer Chemother Pharmacol (2013) 0.89
Breast carcinoma in women 35 years and younger: a pathological study. Pathology (2006) 0.88
BRCA1 and BRCA2 mutations in an Asian clinic-based population detected using a comprehensive strategy. Cancer Epidemiol Biomarkers Prev (2007) 0.88
Casein kinase 1α-dependent feedback loop controls autophagy in RAS-driven cancers. J Clin Invest (2015) 0.87
Novel photodynamic diagnosis of bladder cancer: ex vivo fluorescence cytology using hypericin. Int J Oncol (2003) 0.87
GST-pi expression correlates with oxidative stress and apoptosis in breast cancer. Oncol Rep (2004) 0.87
Mucin extravasation in breast core biopsies--clinical significance and outcome correlation. Histopathology (2009) 0.87
Chronic exposure to U18666A induces apoptosis in cultured murine cortical neurons. Biochem Biophys Res Commun (2004) 0.87
Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle. Int J Oncol (2010) 0.87
Parkin enhances the expression of cyclin-dependent kinase 6 and negatively regulates the proliferation of breast cancer cells. J Biol Chem (2010) 0.87
Dasatinib induces a response in malignant thymoma. J Clin Oncol (2006) 0.86
Expression of FGFR1 is an independent prognostic factor in triple-negative breast cancer. Breast Cancer Res Treat (2015) 0.86
Phosphorothioate oligonucleotides reduce mitochondrial outer membrane permeability to ADP. Am J Physiol Cell Physiol (2006) 0.86
Ductal carcinoma in situ within phyllodes tumour: a rare occurrence. Pathology (2005) 0.86